T1	CHEM 33 45	ácido fólico
#1	AnnotatorNotes T1	C0016410; folic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T2	CHEM 67 79	homocisteína
#2	AnnotatorNotes T2	C0019878; homocysteine; Amino Acid, Peptide, or Protein · Biologically Active Substance
T3	PROC 102 114	hemodiálisis
#3	AnnotatorNotes T3	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T4	DISO 119 139	hiperhomocisteinemia
#4	AnnotatorNotes T4	C0598608; Hyperhomocysteinemia; Disease or Syndrome
T5	ANAT 198 212	cardiovascular
#5	AnnotatorNotes T5	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T6	PROC 260 283	niveles de homocisteína
#6	AnnotatorNotes T6	C2242817; Homocysteine measurement; Laboratory Procedure
T7	CHEM 271 283	homocisteína
#7	AnnotatorNotes T7	C0019878; homocysteine; Amino Acid, Peptide, or Protein · Biologically Active Substance
T8	CHEM 321 333	ácido fólico
#8	AnnotatorNotes T8	C0016410; folic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T9	CHEM 336 347	vitamina B6
#9	AnnotatorNotes T9	C0087162; vitamin B6; Organic Chemical · Vitamin · Pharmacologic Substance | C0034266; pyridoxal phosphate; Organic Chemical · Pharmacologic Substance · Vitamin
T10	PROC 1124 1139	niveles de tHcy
#10	AnnotatorNotes T10	C2242817; Homocysteine measurement; Laboratory Procedure
T11	PROC 488 500	hemodiálisis
#11	AnnotatorNotes T11	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T12	CHEM 542 554	ácido fólico
#12	AnnotatorNotes T12	C0016410; folic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T13	CHEM 558 569	vitamina B6
#13	AnnotatorNotes T13	C0087162; vitamin B6; Organic Chemical · Vitamin · Pharmacologic Substance | C0034266; pyridoxal phosphate; Organic Chemical · Pharmacologic Substance · Vitamin
T14	PROC 642 654	hemodiálisis
#14	AnnotatorNotes T14	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T15	CHEM 682 694	ácido fólico
#15	AnnotatorNotes T15	C0016410; folic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T16	PROC 919 923	tHcy
#16	AnnotatorNotes T16	C2242817; Homocysteine measurement; Laboratory Procedure
T17	CHEM 727 738	vitamina B6
#17	AnnotatorNotes T17	C0087162; vitamin B6; Organic Chemical · Vitamin · Pharmacologic Substance | C0034266; pyridoxal phosphate; Organic Chemical · Pharmacologic Substance · Vitamin
T18	CHEM 818 824	folato
#18	AnnotatorNotes T18	C0178638; folate; Organic Chemical · Vitamin · Pharmacologic Substance
T19	PROC 840 852	inmunoensayo
#19	AnnotatorNotes T19	C0020980; Immunoassay method; Laboratory Procedure
T20	PROC 881 885	urea
#20	AnnotatorNotes T20	C0523961; Urea measurement; Laboratory Procedure (?) | C1318428; Urea clearance measurement; Laboratory Procedure (?)
T21	PROC 925 929	HPLC
#21	AnnotatorNotes T21	C0008562; High pressure liquid chromatography procedure; Laboratory Procedure
T22	PROC 937 940	RIA
#22	AnnotatorNotes T22	C0034580; Radioimmunoassay; Laboratory Procedure
T23	DISO 1030 1050	hiperhomocisteinemia
#23	AnnotatorNotes T23	C0598608; Hyperhomocysteinemia; Disease or Syndrome
T24	PROC 1321 1335	suplementación
#24	AnnotatorNotes T24	C0242297; Dietary Supplementation; Therapeutic or Preventive Procedure
T25	PROC 1232 1235	B12
#25	AnnotatorNotes T25	C0202252; VITAMIN B12 MEASUREMENT; Laboratory Procedure
T26	PROC 1462 1466	tHcy
#26	AnnotatorNotes T26	C2242817; Homocysteine measurement; Laboratory Procedure
T27	PROC 1758 1762	tHcy
#27	AnnotatorNotes T27	C2242817; Homocysteine measurement; Laboratory Procedure
T28	PROC 1375 1381	folato
#28	AnnotatorNotes T28	C0523631; Folic acid measurement; Laboratory Procedure
T29	PROC 2130 2145	niveles de tHcy
#29	AnnotatorNotes T29	C2242817; Homocysteine measurement; Laboratory Procedure
T30	PROC 2072 2076	tHcy
#30	AnnotatorNotes T30	C2242817; Homocysteine measurement; Laboratory Procedure
T31	PROC 1721 1725	tHcy
#31	AnnotatorNotes T31	C2242817; Homocysteine measurement; Laboratory Procedure
T32	PROC 1916 1930	suplementación
#32	AnnotatorNotes T32	C0242297; Dietary Supplementation; Therapeutic or Preventive Procedure
T33	PROC 1540 1554	suplementación
#33	AnnotatorNotes T33	C0242297; Dietary Supplementation; Therapeutic or Preventive Procedure
T34	CHEM 1935 1947	ácido fólico
#34	AnnotatorNotes T34	C0016410; folic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T35	CHEM 1950 1961	vitamina B6
#35	AnnotatorNotes T35	C0087162; vitamin B6; Organic Chemical · Vitamin · Pharmacologic Substance | C0034266; pyridoxal phosphate; Organic Chemical · Pharmacologic Substance · Vitamin
T36	PROC 1996 2000	tHcy
#36	AnnotatorNotes T36	C2242817; Homocysteine measurement; Laboratory Procedure
T37	CHEM 2084 2092	albúmina
#37	AnnotatorNotes T37	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T38	ANAT 2093 2103	plasmática
#38	AnnotatorNotes T38	C0032105; Plasma; Body Substance
T39	CHEM 2187 2195	albúmina
#39	AnnotatorNotes T39	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T40	CHEM 349 351	pp
#40	AnnotatorNotes T40	C0034266; pyridoxal phosphate; Organic Chemical · Pharmacologic Substance · Vitamin
T41	PROC 400 408	diálisis
#41	AnnotatorNotes T41	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T42	PROC 807 824	niveles de folato
#42	AnnotatorNotes T42	C0523631; Folic acid measurement; Laboratory Procedure
T43	PROC 826 838	vitamina B12
#43	AnnotatorNotes T43	C0202252; VITAMIN B12 MEASUREMENT; Laboratory Procedure
T44	PROC 855 863	albúmina
#44	AnnotatorNotes T44	C0201838; Albumin measurement; Laboratory Procedure
T45	PROC 933 935	pp
#45	AnnotatorNotes T45	C4761401; Pyridoxal Phosphate Measurement; Laboratory Procedure
T46	DISO 1062 1075	déficit de pp
T47	CHEM 1073 1075	pp
#46	AnnotatorNotes T47	C0034266; pyridoxal phosphate; Organic Chemical · Pharmacologic Substance · Vitamin
T48	PROC 1088 1094	folato
#47	AnnotatorNotes T48	C0523631; Folic acid measurement; Laboratory Procedure
T49	PROC 1184 1190	folato
#48	AnnotatorNotes T49	C0523631; Folic acid measurement; Laboratory Procedure
T50	PROC 1228 1230	pp
#49	AnnotatorNotes T50	C4761401; Pyridoxal Phosphate Measurement; Laboratory Procedure
T51	PROC 1243 1251	albúmina
#50	AnnotatorNotes T51	C0201838; Albumin measurement; Laboratory Procedure
T52	PROC 1359 1361	pp
#51	AnnotatorNotes T52	C4761401; Pyridoxal Phosphate Measurement; Laboratory Procedure
T53	PROC 1626 1632	folato
#52	AnnotatorNotes T53	C0523631; Folic acid measurement; Laboratory Procedure
T54	PROC 1770 1778	albúmina
#53	AnnotatorNotes T54	C0201838; Albumin measurement; Laboratory Procedure
T55	PROC 2084 2103	albúmina plasmática
#54	AnnotatorNotes T55	C3525688; Measurement of albumin in plasma; Laboratory Procedure
T56	PROC 2170 2195	concentración de albúmina
#55	AnnotatorNotes T56	C0201838; Albumin measurement; Laboratory Procedure (?)
T57	PROC 14 28	suplementación
#56	AnnotatorNotes T57	C0242297; Dietary Supplementation; Therapeutic or Preventive Procedure
T58	PROC 291 295	tHcy
#57	AnnotatorNotes T58	C2242817; Homocysteine measurement; Laboratory Procedure
T59	PROC 410 426	función residual
#58	AnnotatorNotes T59	C0855766; Residual function; Diagnostic Procedure
T60	LIVB 89 98	pacientes
#59	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T63	LIVB 475 484	pacientes
#60	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	Neg_cue 530 532	no
T65	Neg_cue 555 557	ni
T66	Dose 667 671	5 mg
T67	Route 672 678	orales
#61	AnnotatorNotes T67	C1527415; Oral Route of Drug administration; Functional Concept
T68	Frequency 695 708	cada 48 horas
T69	Dose 711 716	40 mg
T70	Route 717 723	orales
#62	AnnotatorNotes T70	C1527415; Oral Route of Drug administration; Functional Concept
T71	Frequency 739 750	cada semana
T72	Frequency 794 806	cada 2 meses
T73	Frequency 906 918	cada 6 meses
T74	LIVB 959 968	pacientes
#63	AnnotatorNotes T74	C0030705; Patients; Patient or Disabled Group
T76	LIVB 1286 1295	pacientes
#64	AnnotatorNotes T76	C0030705; Patients; Patient or Disabled Group
T77	Duration 1307 1317	seis meses
T78	Duration 1563 1571	12 meses
T79	LIVB 1575 1584	pacientes
#65	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T80	LIVB 1681 1690	pacientes
#66	AnnotatorNotes T80	C0030705; Patients; Patient or Disabled Group
T61	Duration 625 638	su tercer mes
T62	DISO 182 212	morbimortalidad cardiovascular
T75	Spec_cue 158 164	riesgo
A1	Assertion T12 Negated
A2	Assertion T13 Negated
A3	Assertion T62 Speculated
T81	PROC 429 453	parámetros nutricionales
#67	AnnotatorNotes T81	C0028708; Nutrition Assessment; Diagnostic Procedure
R1	Used_for Arg1:T1 Arg2:T57	
R2	Experiences Arg1:T60 Arg2:T3	
R3	Experiences Arg1:T60 Arg2:T57	
R5	Speculation Arg1:T75 Arg2:T62	
R6	Location_of Arg1:T5 Arg2:T62	
R7	Before Arg1:T4 Arg2:T62	
T82	PROC 56 79	niveles de homocisteína
#68	AnnotatorNotes T82	C2242817; Homocysteine measurement; Laboratory Procedure
R8	Experiences Arg1:T60 Arg2:T82	
T83	CONC 146 164	marcador de riesgo
#69	AnnotatorNotes T83	C1519104; Risk Marker; Qualitative Concept
R10	Combined_with Arg1:T8 Arg2:T9	
R11	Combined_with Arg1:T8 Arg2:T40	
R17	Experiences Arg1:T63 Arg2:T11	
R18	Negation Arg1:T64 Arg2:T12	
R19	Negation Arg1:T65 Arg2:T13	
R20	Experiences Arg1:T63 Arg2:T12	
R21	Experiences Arg1:T63 Arg2:T13	
R22	Has_Duration_or_Interval Arg1:T14 Arg2:T61	
T85	CONC 504 524	comienzo del estudio
#71	AnnotatorNotes T85	C4684789; Study Start; Temporal Concept
R23	Overlap Arg1:T11 Arg2:T85	
R24	Experiences Arg1:T63 Arg2:T14	
R25	Has_Route_or_Mode Arg1:T15 Arg2:T67	
R26	Has_Dose_or_Strength Arg1:T15 Arg2:T66	
R27	Has_Frequency Arg1:T15 Arg2:T68	
R28	Has_Route_or_Mode Arg1:T17 Arg2:T70	
R29	Has_Frequency Arg1:T17 Arg2:T71	
R30	Has_Dose_or_Strength Arg1:T17 Arg2:T69	
R31	Combined_with Arg1:T15 Arg2:T17	
R32	Experiences Arg1:T63 Arg2:T15	
R9	Before Arg1:T8 Arg2:T107	
T84	CONC 771 791	comienzo del estudio
#70	AnnotatorNotes T84	C4684789; Study Start; Temporal Concept
R16	Overlap Arg1:T42 Arg2:T84	
R33	Overlap Arg1:T43 Arg2:T84	
R34	Overlap Arg1:T19 Arg2:T84	
R35	Overlap Arg1:T44 Arg2:T84	
R36	Overlap Arg1:T20 Arg2:T84	
R37	Has_Frequency Arg1:T42 Arg2:T72	
R38	Has_Frequency Arg1:T43 Arg2:T72	
R39	Has_Frequency Arg1:T19 Arg2:T72	
R40	Has_Frequency Arg1:T44 Arg2:T72	
R41	Has_Frequency Arg1:T16 Arg2:T73	
R42	Has_Frequency Arg1:T21 Arg2:T73	
R43	Has_Frequency Arg1:T45 Arg2:T73	
R44	Has_Frequency Arg1:T22 Arg2:T73	
T86	CONC 887 890	KTV
T87	CONC 892 895	KRU
T88	CONC 897 901	PCRn
R45	Experiences Arg1:T74 Arg2:T23	
R46	Experiences Arg1:T74 Arg2:T46	
#72	AnnotatorNotes T46	C1527330; Pyridoxine Deficiency; Disease or Syndrome (?)
R47	Experiences Arg1:T74 Arg2:T48	
R48	Experiences Arg1:T74 Arg2:T10	
R49	Experiences Arg1:T74 Arg2:T49	
R50	Experiences Arg1:T74 Arg2:T50	
R51	Experiences Arg1:T74 Arg2:T25	
R52	Experiences Arg1:T74 Arg2:T51	
T89	CONC 1253 1256	KTV
T90	CONC 1258 1261	KRU
T91	CONC 1263 1267	PCRn
T92	PROC 992 999	estudio
#73	AnnotatorNotes T92	C0681814; research study; Research Activity
T93	Quantifier_or_Qualifier 1000 1005	basal
#74	AnnotatorNotes T93	C1442488; Baseline; Quantitative Concept
R53	Has_Quantifier_or_Qualifier Arg1:T92 Arg2:T93	
R54	Experiences Arg1:T76 Arg2:T24	
R55	Has_Duration_or_Interval Arg1:T24 Arg2:T77	
R56	Experiences Arg1:T76 Arg2:T52	
R57	Experiences Arg1:T76 Arg2:T28	
T94	Observation 1363 1381	aumento del folato
R58	Experiences Arg1:T76 Arg2:T94	
R59	Before Arg1:T24 Arg2:T106	
R61	Location_of Arg1:T38 Arg2:T55	
R62	Used_for Arg1:T34 Arg2:T32	
R63	Combined_with Arg1:T34 Arg2:T35	
R66	Before Arg1:T32 Arg2:T55	
R67	Experiences Arg1:T79 Arg2:T33	
R68	Has_Duration_or_Interval Arg1:T33 Arg2:T78	
T95	Observation 1614 1632	aumento del folato
#75	AnnotatorNotes T95	C0861135; Folate increased; Finding
R69	Experiences Arg1:T79 Arg2:T95	
R70	Before Arg1:T33 Arg2:T95	
R72	Before Arg1:T24 Arg2:T94	
T96	Observation 1447 1466	descenso de la tHcy
R74	Before Arg1:T24 Arg2:T96	
R75	Experiences Arg1:T76 Arg2:T96	
R76	Experiences Arg1:T76 Arg2:T26	
T97	Observation 1770 1778;1807 1815	albúmina se elevó
#76	AnnotatorNotes T97	C0740469; Increased albumin; Finding
T98	CONC 1832 1838	inicio
#77	AnnotatorNotes T98	C0439659; Beginning; Temporal Concept
R77	After Arg1:T97 Arg2:T98	
R78	Experiences Arg1:T80 Arg2:T31	
R79	Experiences Arg1:T80 Arg2:T27	
R80	Experiences Arg1:T80 Arg2:T54	
R81	Experiences Arg1:T80 Arg2:T97	
R82	Before Arg1:T33 Arg2:T97	
R83	Experiences Arg1:T79 Arg2:T31	
R84	Experiences Arg1:T79 Arg2:T27	
R85	Experiences Arg1:T79 Arg2:T54	
R86	Experiences Arg1:T79 Arg2:T97	
R87	Experiences Arg1:T80 Arg2:T53	
R88	Experiences Arg1:T80 Arg2:T95	
R89	Experiences Arg1:T80 Arg2:T33	
R90	After Arg1:T95 Arg2:T98	
T99	Quantifier_or_Qualifier 284 289	total
R91	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T99	
T100	Observation 1983 2000	se reduce la tHcy
T101	Quantifier_or_Qualifier 80 85	total
R92	Has_Quantifier_or_Qualifier Arg1:T82 Arg2:T101	
#78	AnnotatorNotes T101	C0439810; Total; Qualitative Concept
#79	AnnotatorNotes T99	C0439810; Total; Qualitative Concept
T102	Spec_cue 367 374	posible
T103	CONC 375 386	correlación
A4	Assertion T103 Speculated
#80	AnnotatorNotes T103	C1707520;Correlation; Qualitative Concept
R93	Speculation Arg1:T102 Arg2:T103	
T104	Observation 1 7	Efecto
#81	AnnotatorNotes T104	C1518681; Outcome of Therapy; Finding (?)
R94	Causes Arg1:T57 Arg2:T104	
#82	AnnotatorNotes T94	C0861135; Folate increased; Finding
#83	AnnotatorNotes T96	C0877683; Serum homocysteine decreased; Finding (?) | C0877299; Blood homocysteine decreased; Finding (?)
#84	AnnotatorNotes T100	C0877683; Serum homocysteine decreased; Finding (?) | C0877299; Blood homocysteine decreased; Finding (?)
R4	Before Arg1:T32 Arg2:T100	
T105	Observation 2007 2016	respuesta
#85	AnnotatorNotes T105	C4055223; Clinical Response; Finding
R13	Before Arg1:T32 Arg2:T105	
R64	Before Arg1:T32 Arg2:T30	
R65	Before Arg1:T32 Arg2:T36	
T106	Observation 1341 1361	normalización del pp
T107	Observation 248 296	reducir los niveles de homocisteína total (tHcy)
#86	AnnotatorNotes T107	C0877683; Serum homocysteine decreased; Finding (?) | C0877299; Blood homocysteine decreased; Finding (?)
#87	AnnotatorNotes T88	[normalized Protein Catabolic Rate]
#88	AnnotatorNotes T91	[normalized Protein Catabolic Rate]
A5	Experiencer T60 Patient
A6	Experiencer T63 Patient
A7	Experiencer T74 Patient
A8	Experiencer T76 Patient
A9	Experiencer T79 Patient
A10	Experiencer T80 Patient
R12	Has_Result_or_Value Arg1:T36 Arg2:T100	
R14	Has_Result_or_Value Arg1:T54 Arg2:T97	
R15	Has_Result_or_Value Arg1:T53 Arg2:T95	
R60	Has_Result_or_Value Arg1:T26 Arg2:T96	
R71	Has_Result_or_Value Arg1:T28 Arg2:T94	
R73	Has_Result_or_Value Arg1:T52 Arg2:T106	
R95	Has_Result_or_Value Arg1:T6 Arg2:T107	
